DK0774969T3 - HIV-proteaseinhibitor kombination - Google Patents

HIV-proteaseinhibitor kombination

Info

Publication number
DK0774969T3
DK0774969T3 DK95930118T DK95930118T DK0774969T3 DK 0774969 T3 DK0774969 T3 DK 0774969T3 DK 95930118 T DK95930118 T DK 95930118T DK 95930118 T DK95930118 T DK 95930118T DK 0774969 T3 DK0774969 T3 DK 0774969T3
Authority
DK
Denmark
Prior art keywords
hiv protease
hiv
protease inhibitor
combination
inhibitor combination
Prior art date
Application number
DK95930118T
Other languages
Danish (da)
English (en)
Inventor
Joseph P Vacca
Paul J Deutsch
Emilio A Emini
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of DK0774969T3 publication Critical patent/DK0774969T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK95930118T 1994-08-11 1995-08-07 HIV-proteaseinhibitor kombination DK0774969T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US28947494A 1994-08-11 1994-08-11
US33936994A 1994-11-14 1994-11-14
US49246195A 1995-07-20 1995-07-20
PCT/US1995/009956 WO1996004913A1 (en) 1994-08-11 1995-08-07 Hiv protease inhibitor combination

Publications (1)

Publication Number Publication Date
DK0774969T3 true DK0774969T3 (da) 2003-03-31

Family

ID=27403895

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95930118T DK0774969T3 (da) 1994-08-11 1995-08-07 HIV-proteaseinhibitor kombination

Country Status (19)

Country Link
EP (1) EP0774969B8 (de)
JP (1) JPH10504036A (de)
KR (1) KR970704441A (de)
CN (1) CN1101190C (de)
AT (1) ATE232727T1 (de)
AU (1) AU698664B2 (de)
CA (1) CA2197207C (de)
CY (1) CY2360B1 (de)
CZ (1) CZ292577B6 (de)
DE (1) DE69529678T2 (de)
DK (1) DK0774969T3 (de)
ES (1) ES2190456T3 (de)
HU (1) HUT76540A (de)
IL (1) IL114808A (de)
MX (1) MX9701121A (de)
NO (1) NO314168B1 (de)
PL (1) PL181578B1 (de)
SK (1) SK18197A3 (de)
WO (1) WO1996004913A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA49803C2 (uk) * 1994-06-03 2002-10-15 Дж.Д. Сьорль Енд Ко Спосіб лікування ретровірусних інфекцій
US6037157A (en) * 1995-06-29 2000-03-14 Abbott Laboratories Method for improving pharmacokinetics
CA2270546A1 (en) * 1996-11-08 1998-05-22 Japan Energy Corporation Aids remedy

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US517041A (en) * 1894-03-27 Fruit-picker
CA1340588C (en) * 1988-06-13 1999-06-08 Balraj Krishan Handa Amino acid derivatives
CA2096408C (en) * 1990-11-19 2005-02-08 Gary Anthony Decrescenzo Retroviral protease inhibitors
DK0558657T3 (da) * 1990-11-19 1997-07-07 Monsanto Co Retrovirale proteaseinhibitorer
IE913840A1 (en) * 1990-11-20 1992-05-20 Abbott Lab Retroviral protease inhibiting compounds
ATE163926T1 (de) * 1991-11-08 1998-03-15 Merck & Co Inc Hiv-protease-inhibitoren verwendbar in der aids- behandlung
EP1302468B1 (de) * 1992-12-29 2008-12-17 Abbott Laboratories Verfahren und Intermediate zur Herstellung von retroviralen Proteasehemmern

Also Published As

Publication number Publication date
NO970632L (no) 1997-04-10
CA2197207A1 (en) 1996-02-22
SK18197A3 (en) 1997-09-10
ATE232727T1 (de) 2003-03-15
CA2197207C (en) 2006-10-17
NO970632D0 (no) 1997-02-11
DE69529678T2 (de) 2003-09-25
HUT76540A (en) 1997-09-29
EP0774969B1 (de) 2003-02-19
PL318506A1 (en) 1997-06-23
AU698664B2 (en) 1998-11-05
AU3361195A (en) 1996-03-07
IL114808A (en) 1999-10-28
CN1101190C (zh) 2003-02-12
CZ292577B6 (cs) 2003-10-15
JPH10504036A (ja) 1998-04-14
EP0774969B8 (de) 2003-07-02
MX9701121A (es) 1997-05-31
EP0774969A1 (de) 1997-05-28
DE69529678D1 (de) 2003-03-27
KR970704441A (ko) 1997-09-06
IL114808A0 (en) 1995-12-08
NO314168B1 (no) 2003-02-10
PL181578B1 (pl) 2001-08-31
CN1160350A (zh) 1997-09-24
ES2190456T3 (es) 2003-08-01
WO1996004913A1 (en) 1996-02-22
CY2360B1 (en) 2004-06-04
CZ38997A3 (en) 1997-11-12

Similar Documents

Publication Publication Date Title
ATE175412T1 (de) Hiv-protease-inhibitoren
DE60036961D1 (de) Gamma-hydroxy-2-(fluoralkylaminocarbonyl)-1-piperazinpentanamide als hiv-proteasehemmer
MY109834A (en) Benzoxazinones as inhibitors of hiv reverse transcriptase
DE69531944D1 (de) Neue hiv-protease-inhibitoren
ATE215952T1 (de) Hiv-proteaseinhibitoren
DZ1766A1 (fr) Inhibiteurs de vih protéase utiles pour le traitement du sida.
YU6396A (sh) Kombinacija inhibitora hiv proteaze sa drugim jedinjenjima za terapiju hiv infekcija
ATE404563T1 (de) 8-hydroxy-1- oxotetrahydropyrrolopyrazinverbindungen, die sich als inhibitoren von hiv-integrase eignen
WO1996000068A3 (en) Combination therapy for hiv infection
DK0774969T3 (da) HIV-proteaseinhibitor kombination
FI970565A0 (fi) HIV-proteaasia inhiboiva yhdistelmä
WO2002096359A3 (en) Piperazine pentanamide hiv protease inhibitors